Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

479
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
479
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

515
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
515
Management of Insomnia01:19

Management of Insomnia

536
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
536
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

771
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
771
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

400
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
400
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

1.4K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Take-Home Heart Monitoring Boom.

IEEE pulse·2026
Same author

Lighting the Way to Treat Advanced Stomach Cancer.

IEEE pulse·2026
Same author

From Headsets to Healing: The Rise of Wearable Brain Tech and Its Impact on Mental Illness and Cognitive Health.

IEEE pulse·2025
Same author

Tracking Sleep to Optimize Health.

IEEE pulse·2020
Same author

Detecting Faces, Saving Lives.

IEEE pulse·2020
Same author

The State of Nanorobotics in Medicine.

IEEE pulse·2019

Related Experiment Video

Updated: Jan 15, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.5K

Flipping the Script: How New Drugs Are Disrupting Sleep Apnea Care.

Kristina Grifantini

    IEEE Pulse
    |October 13, 2025
    PubMed
    Summary
    This summary is machine-generated.

    New pharmaceutical interventions are transforming obstructive sleep apnea (OSA) treatment. Emerging weight loss drugs offer novel therapeutic options for managing this common sleep disorder.

    More Related Videos

    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
    05:59

    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

    Published on: October 20, 2023

    3.0K
    Multi-Modal Home Sleep Monitoring in Older Adults
    07:40

    Multi-Modal Home Sleep Monitoring in Older Adults

    Published on: January 26, 2019

    8.1K

    Related Experiment Videos

    Last Updated: Jan 15, 2026

    Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
    07:54

    Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

    Published on: December 6, 2016

    20.5K
    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
    05:59

    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

    Published on: October 20, 2023

    3.0K
    Multi-Modal Home Sleep Monitoring in Older Adults
    07:40

    Multi-Modal Home Sleep Monitoring in Older Adults

    Published on: January 26, 2019

    8.1K

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Obesity Research

    Background:

    • Obstructive sleep apnea (OSA) is a prevalent condition often linked to obesity.
    • Current OSA treatments, such as CPAP, have limitations in adherence and effectiveness for some patients.
    • Emerging pharmaceutical agents present new avenues for OSA management.

    Purpose of the Study:

    • To examine the impact of novel pharmaceutical interventions on obstructive sleep apnea care.
    • To specifically evaluate the role of weight loss drugs in disrupting traditional OSA treatment paradigms.
    • To explore alternative therapeutic options beyond current standards of care.

    Main Methods:

    • Review of recent clinical trials and pharmacological studies.
    • Analysis of drug efficacy data related to OSA symptoms and associated comorbidities.
    • Comparative assessment of new pharmaceutical interventions against established OSA therapies.

    Main Results:

    • Certain weight loss drugs demonstrate significant improvements in OSA severity.
    • Pharmaceutical interventions show potential for addressing underlying physiological factors in OSA.
    • Emerging therapies may offer improved patient adherence and quality of life.

    Conclusions:

    • New drug classes, particularly weight loss medications, are poised to significantly alter obstructive sleep apnea management.
    • Pharmaceuticals represent a promising adjunct or alternative to traditional OSA therapies.
    • Further research is warranted to optimize the integration of these novel agents into clinical practice.